Simon Caidan
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 10%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 13
- COVID-19 Clinical Research Studies 10
- SARS-CoV-2 detection and testing 5
- Oncology 6
- COVID-19 and healthcare impacts 5
- Co-authors
- Sooyoung Chung (1 shared paper)
- Journals
- Cancer Cell (3 papers)The Lancet (3 papers)Wellcome Open Research (2 papers)Nature Cancer (2 papers)Epilepsy & Behavior (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Simon Caidan
18 papers receiving 672 citations
Peers
Comparison fields: 5 of 56
- Infectious Diseases 483
- Modeling and Simulation 44
- Oncology 177
- Health 40
- Immunology 65
Countries citing papers authored by Simon Caidan
This map shows the geographic impact of Simon Caidan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Caidan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Caidan more than expected).
Fields of papers citing papers by Simon Caidan
This network shows the impact of papers produced by Simon Caidan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Caidan. The network helps show where Simon Caidan may publish in the future.
Co-authors
The 1 scholars most cited alongside Simon Caidan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 155 | |
| 2 | 2021 | 140 | |
| 3 | 2021 | 69 | |
| 4 | 2021 | 67 | |
| 5 | Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer | 2022 | 60 |
| 6 | 2021 | 52 | |
| 7 | 2020 | 24 | |
| 8 | 2022 | 19 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2023 | 13 | |
| 13 | 2020 | 13 | |
| 14 | 2023 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2023 | 6 | |
| 17 | 1985 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2024 | 0 |
About Simon Caidan
Simon Caidan is a scholar working on Infectious Diseases, Oncology, Health, Neurology and Immunology, having authored 19 papers that have together received 682 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 detection and testing (5 papers), COVID-19 and healthcare impacts (5 papers), Biosensors and Analytical Detection (3 papers), Vaccine Coverage and Hesitancy (2 papers), Immunotherapy and Immune Responses (2 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Infectious Diseases (483 citations), Modeling and Simulation (44 citations), Oncology (177 citations), Health (40 citations) and Immunology (65 citations). Simon Caidan has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Sooyoung Chung. Their work appears in journals such as Cancer Cell, The Lancet, Wellcome Open Research, Nature Cancer and Epilepsy & Behavior.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.